The machine is developed according to the requirements of the PVC resin market for large-volume centrifuges. It is the largest size bedroom centrifuge in China. Compared with D6NC and D5MC centrifuges, the D7NC centrifuge is more reasonable in design and more suitable for users. The need for scale production.
According to statistics, in 2005 China's demand for PVC resin reached 8 million tons, while the domestic century production capacity was only 6.5 million tons. It is estimated that by 2010, China's demand for PVC resin will reach 12 million tons, so the demand for horizontal screw centrifuge products with large specifications and large processing capacity will increase greatly in the PVC market.
Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid.
Empagliflozin is a C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It has a role as a sodium-glucose transport protein subtype 2 inhibitor and a hypoglycemic agent. It is a C-glycosyl compound, an aromatic ether, a tetrahydrofuryl ether and a member of monochlorobenzenes.
Empagliflozin; 864070-44-0; JARDIANCE; BI 10773; Empagliflozin (BI 10773);
 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com